Liquiritin

CAS No. 551-15-5

Liquiritin( Liquiritoside | Likviritin | Liquiritin )

Catalog No. M18791 CAS No. 551-15-5

Liquiritin is sompound extracted from Radix liquiritiae.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 35 In Stock
10MG 58 In Stock
25MG 115 In Stock
50MG 178 In Stock
100MG 295 In Stock
500MG 709 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Liquiritin
  • Note
    Research use only, not for human use.
  • Brief Description
    Liquiritin is sompound extracted from Radix liquiritiae.
  • Description
    Liquiritoside is a flavonoid complex isoalted from Glycyrrhizae radix.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Liquiritoside | Likviritin | Liquiritin
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    Phospholipase
  • Recptor
    Others
  • Research Area
    Neurological Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    551-15-5
  • Formula Weight
    418.39
  • Molecular Formula
    C21H22O9
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : 150 mg/mL 358.52 mM
  • SMILES
    C1[C@H](Oc2c(C1=O)ccc(c2)O)c1ccc(cc1)O[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)O
  • Chemical Name
    (S)-7-hydroxy-2-(4-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)phenyl)chroman-4-one

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Zhang W, et al. Biomed Chromatogr. 2014 Sep;28(9):1271-7.
molnova catalog
related products
  • Giripladib

    Giripladib (PLA695)(PLX-695) is a cPLA2-specific inhibitor that inhibits the radiation-induced increase of phosphorylated ERK and phosphorylated Akt in endothelial cells.

  • Lp-PLA2-IN-3

    Lp-PLA2-IN-3 is a potent, orally bioactive lipoprotein-associated phospholipase A2 (Lp-PLA2) inhibitor, effectively inhibiting recombinant human [Lp-PLA2] with an IC50 value of 14 nM.

  • LEI110

    LEI110 is a potent Phospholipase A2, group XVI (PLA2G16) inhibitor with an Ki value of 20 nM. LEI110 is a selective pan-inhibitor of the HRASLS family of thiol hydrolases (i.e., PLA2G16, HRASLS2, RARRES3 and iNAT).